Summary
Updated Aug 31, 2026
Alan Mateo files SEC Form 4 reports at 10x Genomics, Inc. (TXG). 1 SEC Form 4 filing on record, dated 8 June 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Alan Mateo has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Alan Mateo files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Serge Saxonov - $4.79M of TXG open-market activity in the last 12 months
- Adam Taich - $1.84M of TXG open-market activity in the last 12 months
- Benjamin J. Hindson - $1.46M of TXG open-market activity in the last 12 months
- John R. Stuelpnagel - $1.16M of TXG open-market activity in the last 12 months
- Sarah A. Teichmann - $579K of TXG open-market activity in the last 12 months
- Shehnaaz Suliman - $327K of TXG open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Alan Mateo?
Alan Mateo is a corporate insider of 10x Genomics, Inc. (TXG). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Alan Mateo submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Alan Mateo's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Alan Mateo and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
